| Literature DB >> 33868803 |
Jianjie Li1, Xuan Yu1, Yuqi Gao2.
Abstract
BACKGROUND: The hypoxia-inducible factor-1 (HIF-1) signaling pathway is an important topic in high-altitude medicine. Network analysis is a novel method for integrating information on different aspects and levels of biological networks. However, this method has not been used in research on the HIF-1 signaling pathway network. To introduce this method into HIF-1-related research fields and verify its feasibility and effectiveness, we used a network analytical method to explore the structural attributes of the HIF-1 signaling pathway network.Entities:
Keywords: Bow-tie structure; Complex networks; Network topology; Structural complexity; Hypoxia response network
Year: 2021 PMID: 33868803 PMCID: PMC8034363 DOI: 10.7717/peerj.10985
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Figure 1The bow-tie structure of the network.
This structure is composed of the input section, the core section of strong connection, the output section, the tendril section, the pipeline section, and the component with no connection.
Figure 2The subnet distribution map of the overall network of the HIF-1 signaling pathway.
The numbers beside a node identifies the node. The color of the node and the number in square brackets identify the subnet to which the node belongs. The square nodes, round nodes, and elliptical nodes represent the orthologous enzymes, compounds, and pathways involved in metabolism, respectively. An arrow represents a metabolic association relationship. The shaft of the arrow connects the metabolic reactant, and the arrowhead connects the metabolites. The solid black line indicates the “activated” metabolic behavior, while the solid blue line indicates the “expression” metabolic behavior. Moreover, the red dashed line indicates “suppressive” metabolic behavior.
Figure 3The core network bow-tie structure of the HIF-1 signaling pathway.
According to the analysis results, the bow-tie structure of the core network of the HIF-1 signaling pathway includes three types of components. The first is a strongly connected core, corresponding to the yellow node, ko: K08268, in the figure, and the corresponding reactant in the KEGG database is HIF-1 α. The second is the input components, including 20 green nodes, such as ko: K09592, corresponding to 20 reactants, such as PHD (EGLN, HPH), in the KEGG database. The third is a tendril-like structure including 13 pink nodes, such as ko: K04526, ko: K04357, and ko: K05459, which correspond to 13 reactants, such as GF (INS, EGF, IGF1), in the KEGG database.
Top 10 nodes of the overall network degree centrality of the HIF-1 signaling pathway.
| Rank | Overall degree centrality | Input degree centrality | Output degree centrality | |||
|---|---|---|---|---|---|---|
| Node number | Value | Node number | Value | Node number | Value | |
| 1 | 85 | 24 | 6 | 6 | 85 | 24 |
| 2 | 6 | 7 | 10 | 4 | 24 | 2 |
| 3 | 10 | 4 | 61 | 2 | 23 | 2 |
| 4 | 20 | 4 | 20 | 2 | 20 | 2 |
| 5 | 61 | 3 | 74 | 2 | 78 | 2 |
| 6 | 24 | 3 | 60 | 1 | 17 | 2 |
| 7 | 23 | 3 | 80 | 1 | 63 | 1 |
| 8 | 78 | 3 | 29 | 1 | 62 | 1 |
| 9 | 17 | 3 | 78 | 1 | 61 | 1 |
| 10 | 60 | 2 | 58 | 1 | 60 | 1 |
Top 10 nodes of the overall network closeness degree centrality of the HIF-1 signaling pathway.
| Rank | Overall closeness centrality | Input closeness centrality | Output closeness centrality | |||
|---|---|---|---|---|---|---|
| Node number | Value | Node number | Value | Node number | Value | |
| 1 | 85 | 0.2941 | 10 | 0.1008 | 85 | 0.2941 |
| 2 | 29 | 0.1502 | 6 | 0.0647 | 17 | 0.0462 |
| 3 | 58 | 0.1502 | 74 | 0.051 | 24 | 0.0449 |
| 4 | 57 | 0.1502 | 20 | 0.0424 | 12 | 0.0398 |
| 5 | 82 | 0.1502 | 61 | 0.0392 | 23 | 0.0392 |
| 6 | 56 | 0.1502 | 76 | 0.037 | 25 | 0.0366 |
| 7 | 55 | 0.1502 | 77 | 0.0338 | 20 | 0.0353 |
| 8 | 54 | 0.1502 | 82 | 0.0235 | 78 | 0.0353 |
| 9 | 53 | 0.1502 | 60 | 0.0235 | 27 | 0.035 |
| 10 | 52 | 0.1502 | 29 | 0.0235 | 22 | 0.0324 |
Top 10 nodes of the overall network betweenness degree centrality of the HIF-1 signaling pathway.
| Rank | Node number | Value |
|---|---|---|
| 1 | 20 | 0.0036 |
| 2 | 24 | 0.0034 |
| 3 | 25 | 0.003 |
| 4 | 23 | 0.0026 |
| 5 | 27 | 0.0014 |
| 6 | 6 | 0.0014 |
| 7 | 19 | 0.0014 |
| 8 | 76 | 0.0014 |
| 9 | 17 | 0.0014 |
| 10 | 78 | 0.0013 |
The maximum connected subnet distribution of the overall network of the HIF-1 signaling pathway.
| Subnet number | Number of nodes included | Cumulative number of nodes | Representative network node number | ||
|---|---|---|---|---|---|
| % | % | ||||
| 1 | 1 | 1.1765 | 1 | 1.1765 | 1 |
| 2 | 1 | 1.1765 | 2 | 2.3529 | 2 |
| 3 | 1 | 1.1765 | 3 | 3.5294 | 3 |
| 4 | 1 | 1.1765 | 4 | 4.7059 | 4 |
| 5 | 25 | 29.4118 | 29 | 34.1176 | 5 |
| 6 | 34 | 40 | 63 | 74.1176 | 6 |
| 7 | 1 | 1.1765 | 64 | 75.2941 | 7 |
| 8 | 1 | 1.1765 | 65 | 76.4706 | 8 |
| 9 | 3 | 3.5294 | 68 | 80 | 9 |
| 10 | 1 | 1.1765 | 69 | 81.1765 | 13 |
| 11 | 1 | 1.1765 | 70 | 82.3529 | 14 |
| 12 | 1 | 1.1765 | 71 | 83.5294 | 15 |
| 13 | 1 | 1.1765 | 72 | 84.7059 | 16 |
| 14 | 1 | 1.1765 | 73 | 85.8824 | 21 |
| 15 | 1 | 1.1765 | 74 | 87.0588 | 11 |
| 16 | 1 | 1.1765 | 75 | 88.2353 | 30 |
| 17 | 1 | 1.1765 | 76 | 89.4118 | 31 |
| 18 | 1 | 1.1765 | 77 | 90.5882 | 32 |
| 19 | 1 | 1.1765 | 78 | 91.7647 | 33 |
| 20 | 1 | 1.1765 | 79 | 92.9412 | 34 |
| 21 | 2 | 2.3529 | 81 | 95.2941 | 35 |
| 22 | 1 | 1.1765 | 82 | 96.4706 | 37 |
| 23 | 1 | 1.1765 | 83 | 97.6471 | 59 |
| 24 | 1 | 1.1765 | 84 | 98.8235 | 65 |
| 25 | 1 | 1.1765 | 85 | 100 | 81 |
The quantity distribution of the nodes in the core network of the HIF-1 signaling pathway.
| Structure category | Frequency of occurrence | Cumulative frequency | Representative reactants | ||
|---|---|---|---|---|---|
| % | % | ||||
| The core section of strong connection | 1 | 2.9412 | 1 | 2.9412 | hypoxia-inducible factor 1 alpha |
| The input section | 20 | 58.8235 | 21 | 61.7647 | hypoxia-inducible factor prolyl hydroxylase |
| The tendril-like section | 13 | 38.2353 | 34 | 100 | Insulin, epidermal growth factor, insulin-like growth factor 1 |
The biological meanings of the vertices in the core network of the HIF-1 signaling pathway.
| 1 | ko:K09592 | EGLN, HPH | hypoxia-inducible factor prolyl hydroxylase [EC:1.14.11.29] | IN |
| 2 | ko:K08268 | HIF1A | hypoxia-inducible factor 1 alpha | LSSC: Largest Strongly Connected Component |
| 3 | ko:K04526 | INS | insulin | TENDRILS |
| 3 | ko:K04357 | EGF | epidermal growth factor | TENDRILS |
| 3 | ko:K05459 | IGF1 | insulin-like growth factor 1 | TENDRILS |
| 4 | ko:K04527 | INSR, CD220 | insulin receptor [EC:2.7.10.1] | TENDRILS |
| 4 | ko:K04361 | EGFR, ERBB1 | epidermal growth factor receptor [EC:2.7.10.1] | TENDRILS |
| 4 | ko:K05087 | IGF1R, CD221 | insulin-like growth factor 1 receptor [EC:2.7.10.1] | TENDRILS |
| 4 | ko:K05083 | ERBB2, HER2, CD340 | receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1] | TENDRILS |
| 5 | ko:K02649 | PIK3R1_2_3 | phosphoinositide-3-kinase regulatory subunit alpha/beta/delta | TENDRILS |
| 5 | ko:K00922 | PIK3CA_B_D | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153] | TENDRILS |
| 6 | ko:K04456 | AKT | RAC serine/threonine-protein kinase [EC:2.7.11.1] | TENDRILS |
| 7 | ko:K07203 | MTOR, FRAP, TOR | serine/threonine-protein kinase mTOR [EC:2.7.11.1] | TENDRILS |
| 8 | ko:K08008 | NOX1, MOX1 | NADPH oxidase 1 | IN |
| 9 | ko:K01116 | PLCG1 | phosphatidylinositol phospholipase C, gamma-1 [EC:3.1.4.11] | IN |
| 9 | ko:K05859 | PLCG2 | phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11] | IN |
| 10 | ko:K02677 | PRKCA | classical protein kinase C alpha type [EC:2.7.11.13] | IN |
| 10 | ko:K19662 | PRKCB | classical protein kinase C beta type [EC:2.7.11.13] | IN |
| 10 | ko:K19663 | PRKCG | classical protein kinase C gamma type [EC:2.7.11.13] | IN |
| 11 | cpd:C00165 | Diacylglycerol;Diglyceride | Generic compound in reaction hierarchyIncluding 1,2-Diacyl-sn-glycerol [CPD:C00641] and 2,3-Diacyl-sn-glycerol | IN |
| 12 | cpd:C01245 | D-myo-Inositol 1,4,5-trisphosphate;1D-myo-Inositol 1,4,5-trisphosphate;Inositol 1,4,5-trisphosphate;Ins(1,4,5)P3 | TENDRILS | |
| 13 | cpd:C00704 | Superoxide;O2.-;Superoxide anion;O2- | IN | |
| 14 | ko:K10160 | TLR4, CD284 | toll-like receptor 4 | IN |
| 15 | ko:K04735 | RELA | transcription factor p65 | IN |
| 15 | ko:K02580 | NFKB1 | nuclear factor NF-kappa-B p105 subunit | IN |
| 16 | cpd:C00338 | Lipopolysaccharide;LPS | IN | |
| 17 | ko:K04687 | IFNG | interferon gamma | IN |
| 18 | ko:K05132 | IFNGR1, CD119 | interferon gamma receptor 1 | IN |
| 18 | ko:K05133 | IFNGR2 | interferon gamma receptor 2 | IN |
| 19 | ko:K05405 | IL6 | interleukin 6 | IN |
| 20 | ko:K05055 | IL6R, CD126 | interleukin 6 receptor | IN |
| 21 | ko:K04692 | STAT3 | signal transducer and activator of transcription 3 | IN |
| 22 | cpd:C00533 | Nitric oxide;NO;Nitrogen monoxide | IN | |
| 23 | cpd:C00007 | Oxygen;O2 | IN | |
| 24 | cpd:C14818 | Fe2+;Fe(II);Ferrous ion;Iron(2+) | IN | |
| 25 | cpd:C00072 | Ascorbate;Ascorbic acid;L-Ascorbate;L-Ascorbic acid;Vitamin C | IN | |
| 26 | cpd:C00026 | 2-Oxoglutarate;Oxoglutaric acid;2-Ketoglutaric acid;alpha-Ketoglutaric acid | IN | |
| 27 | ko:K07205 | EIF4EBP1 | eukaryotic translation initiation factor 4E binding protein 1 | TENDRILS |
| 28 | ko:K03259 | EIF4E | translation initiation factor 4E | TENDRILS |
| 29 | ko:K04688 | RPS6KB | ribosomal protein S6 kinase beta [EC:2.7.11.1] | TENDRILS |
| 30 | ko:K02991 | RP-S6e, RPS6 | small subunit ribosomal protein S6e | TENDRILS |
| 31 | ko:K04371 | ERK, MAPK1_3 | mitogen-activated protein kinase 1/3 [EC:2.7.11.24] | TENDRILS |
| 32 | ko:K04368 | MAP2K1, MEK1 | mitogen-activated protein kinase kinase 1 [EC:2.7.12.2] | TENDRILS |
| 32 | ko:K04369 | MAP2K2, MEK2 | mitogen-activated protein kinase kinase 2 [EC:2.7.12.2] | TENDRILS |
| 33 | ko:K04372 | MKNK, MNK | MAP kinase interacting serine/threonine kinase [EC:2.7.11.1] | TENDRILS |
| 34 | undefined | IN |
The degree distribution of the core network of the HIF-1 signaling pathway.
| Degree | Frequency of occurrence | Cumulative frequency | Representative reactants | ||
|---|---|---|---|---|---|
| % | % | ||||
| 1 | 14 | 41.1765 | 14 | 41.1765 | Insulin, epidermal growth factor, insulin-like growth factor 1 |
| 2 | 12 | 35.2941 | 26 | 76.4706 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta, phosphoinositide-3-kinase regulatory subunit alpha/beta/delta |
| 3 | 5 | 14.7059 | 31 | 91.1765 | insulin receptor, epidermal growth factor receptor, insulin-like growth factor 1 receptor, receptor tyrosine-protein kinase erbB-2 |
| 4 | 2 | 5.8824 | 33 | 97.0588 | hypoxia-inducible factor 1 alpha |
| 7 | 1 | 2.9412 | 34 | 100 | hypoxia-inducible factor prolyl hydroxylase |
Figure 4Power-law fitting of the core network scale of the HIF-1 signaling pathway.
The abscissa corresponds to the network scale. The ordinate is the distribution rate of the network scale. The black square points are the actual measured power-law distribution points. The dotted line is the slope of the fitted straight line.